CuraLife is starting a new clinical trial of Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Curalin As Add-On Therapy in Adults with Type 2 Diabetes Mellitus.
The clinical trial started in October 15, 2021 and will continue throughout June 30, 2023. The locations are the Soroka Medical Center, Be'er Sheva, Israel; Lin Medical Center, Haifa, Israel; Herzelia Diebetes Center, Herzliya, Israel; Ichilov Medical Center, Tel Aviv, Israel.
For the inclusion and exclusion criteria please follow the link: https://ichgcp.net/clinical-trials-registry/NCT05631431.